Top Tweets for #LSBC18

over 7 years ago

As the cost of sequencing continues to fall, genomic testing will likely become widespread in all types of metastatic cancer, including breast cancer, said George W. Sledge, MD, in a presentation at #LSBC18 https://t.co/OJpA06mFtU

0

3

0

over 7 years ago

Although phyllodes tumors represent approximately 1% of breast cancers and can be primarily treated with surgery, there are challenges with managing the disease if it metastasizes, according to Andrea V. Barrio, MD #bcsm #LSBC18 https://t.co/nnEXXmq6ml

0

2

1

0

over 7 years ago

Dr. Mittendorf of @DanaFarber Discusses Rationale for Updating the AJCC Staging System #LSBC18 https://t.co/ZVIO15IILV

0

3

0

over 7 years ago

This weekend at #lsbc18 I saw the amazing @SpiveySandra She has lived MBC for an amazing 23 years. (Median survival for metastatic breast cancer is 2.5 to 3 years. ) Check out her story...she is holding a 9 ft. long chart of her tx. https://t.co/gfh2z7aCUy #bcsm

MBCNbuzz's tweet photo. This weekend at #lsbc18 I saw the amazing @SpiveySandra She has lived MBC for an amazing 23 years. (Median survival for metastatic breast cancer is 2.5 to 3 years. ) Check out her story...she is holding a 9 ft. long chart of her tx. https://t.co/gfh2z7aCUy #bcsm https://t.co/Fbmafe5aVH

1

15

5

0

over 7 years ago

#lsbc18 Here's a Twitter Transcript of the 2018 Lynn Sage Breast Cancer Symposium @LurieCancer https://t.co/nqKfTvMUql via @symplur

0

5

6

0

over 7 years ago

Top Influencers of #lsbc18 👉 @ihatebreastcanc @LurieCancer @SpiveySandra @IBCResearch @OncLive https://t.co/idtzSYBVWy via @symplur

1

4

1

0

over 7 years ago

Top Influencers of #lsbc18 👉 @DrWGradishar @LurieCancer @antonyruggeri @jennpincus @OncLive https://t.co/idtzSYBVWy via @symplur

0

4

1

0

over 7 years ago

Dr. Ruddy on the Importance of Genetic Testing in Breast Cancer @MayoCancerCare #bcsm #LSBC18 https://t.co/MYg75m3S0m

0

over 7 years ago

“The recurrence score, in particular, is very helpful for ruling out the benefit of adjuvant chemotherapy for patients with N0 and N1 disease," said Burstein #LSBC18 https://t.co/JNyw86jlsl

0

2

0

over 7 years ago

George Sledge, Jr., MD, of @StanfordCancer, discusses the benefit to the cost of genomic sequencing decreasing overtime #LSBC18 #bcsm https://t.co/52cp3CEfte

0

1

0

over 7 years ago

Younger women benefit from the addition of chemotherapy to tamoxifen and ovarian suppression may enhance survival rates, “but ovarian suppression provides a relatively small benefit and can come with significant treatment burdens,” said Robson #LSBC18 https://t.co/YPdhNM29VI

0

1

0

Danielle Ternyila @DaniTernyila

over 7 years ago

Some may not know that the @LynnSage #LSBC18 conference is dedicated to the memory of a woman who died from metastatic breast cancer at age 39. #weremember https://t.co/e6nKnqvYq1

over 7 years ago

I had the chance to ask Dr. Gradishar, chair at #LSBC18, to discuss #BreastCancerAwarenessMonth. He highlighted some points we often miss during this month. Great to hear his thoughts in #BreastCancer research! #bcsm

0

8

4

0

2

1

0

Danielle Ternyila @DaniTernyila

over 7 years ago

Thanks @DrWGradishar @LurieCancer for acknowledging that #BreastCancerAwarenessMonth often overlooks those living with Advanced Breast Cancer aka #Metastatic Breast Cancer. Thank for hearing us and telling our story #LSBC18

over 7 years ago

I had the chance to ask Dr. Gradishar, chair at #LSBC18, to discuss #BreastCancerAwarenessMonth. He highlighted some points we often miss during this month. Great to hear his thoughts in #BreastCancer research! #bcsm

0

8

4

0

4

2

0